PodcastThe Directors The Directors: UPMC’s Byrd and Jefferson’s Chapman speak about avoiding catastrophism and using bridge funding to keep labs open“There’s a tightening of the belt, and when the belt gets tightened, it has downstream effects.” April 24, 2026Vol.52 No.16By Claire Marie Porter and Paul Goldberg
NCI At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylinesThere’s “clear evidence that funding is moving and the system is working.” April 24, 2026Vol.52 No.16By Sara Willa Ernst
Problem: Misinformation and stigma prevent uptake of HPV vaccines and screening. Solution: A comic book April 24, 2026Vol.52 No.16By Jacquelyn Cobb
Guest Editorial Directing the narrative of your survival: How The Remission Film Festival centers survivorship stories April 24, 2026Vol.52 No.16By Edward Miskie
Guest Editorial Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally April 24, 2026Vol.52 No.16By Robert Peter Gale
Cancer Policy Kennedy hints at intended USPSTF reforms at Senate Finance Committee hearing April 24, 2026Vol.52 No.16By Claire Marie Porter
Cancer Policy Senators press Kennedy to release details on Most Favored Nation drug deals April 24, 2026Vol.52 No.16By Claire Marie Porter
Cancer Policy Former deputy surgeon general Erica Schwartz nominated as CDC director April 24, 2026Vol.52 No.16By Claire Marie Porter
Cancer Policy One year of reducing animal testing in drug development April 24, 2026Vol.52 No.16By Claire Marie Porter
Cancer Policy FDA and CMS announce RAPID coverage pathway aimed at accelerating patient access to some Breakthrough medical devices April 24, 2026Vol.52 No.16
